Back Fresenius SE Catalan Fresenius SE Danish Fresenius (Unternehmen) German Fresenius Spanish Fresenius Basque فرزنیوس Persian Fresenius Finnish Fresenius French Fresenius (perusahaan) ID Fresenius (azienda) Italian
&sq=JSO&lang=en&file=File:Fresenius.svg){kind=small} | |
| Company type | Kommanditgesellschaft auf Aktien with Societas Europaea as partner with unlimited liability |
|---|---|
| FWB: FRE DAX Component | |
| ISIN | DE0005785604  |
| Industry | Health care |
| Founded | 1912 |
| Founder | Eduard Fresenius |
| Headquarters | Bad Homburg vor der Höhe, Germany |
Key people | Helen Giza (CEO and chairman of the management board) Wolfgang Kirsch (Chairman of the supervisory board) |
| Products | infusion pumps, medication, hospitals, medical care |
| Services | Dialysis |
| Revenue |  €37.250 billion (2021)[1] |
 €4.252 billion (2021)[1] | |
| €1.867 billion (2021)[1] | |
| Total assets | €71.962 billion (2021)[1] |
| Total equity | €29.288 billion (2021)[1] |
| Owner | Else Kröner-Fresenius Foundation (26.6%) |
Number of employees | 316,078 (2021)[1][dead link] |
| Website | www |
Fresenius SE & Co. KGaA is a European multinational health care company based in Bad Homburg vor der Höhe, Germany. It provides products and services for dialysis in hospitals, as well as inpatient and outpatient medical care. The company is involved in hospital management and in engineering and services for medical centers and other health care facilities.
The company is ranked 411th in the Forbes Global 2000 list in 2023.[2]
In March 2022, it announced plans to merge with InterWell Health and Cricket Health to form a new company, which will operate under the InterWell Health brand, focused on services for the earlier stages of kidney disease.[3]
- ^ a b c d e f "Fresenius. Annual Report 2021" (PDF). Archived from the original (PDF) on 22 June 2022. Retrieved 2 April 2022.
- ^ "Fresenius". Forbes.
- ^ Landi, Heather (21 March 2022). "3 kidney care providers—Fresenius Health Partners, Cricket Health and InterWell Health—plan to merge in deal valued at $2.4B". Fierce healthcare. Retrieved 28 March 2022.
© MMXXIII Rich X Search. We shall prevail. All rights reserved. Rich X Search